Axsome Therapeutics, Inc. (AXSM): A Bull Case Theory

We came across a bullish thesis on Axsome Therapeutics, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on AXSM. Axsome Therapeutics, Inc.'s share was trading at $163.19 as of February 26th. AXSM’s forward P/E was 370.37 according to Yahoo Finance. A bottle with pills Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system disorders in the United States. Axsome Therapeutics, is emerging a ...